(Report) 45th Breakfast Meeting
date : 9/19/2013
![(Report) 45th Breakfast Meeting](https://hgpi.org/en/wp-content/uploads/sites/2/001 010.jpg)
In May 2013, as a result of how the Hollywood actress Angelina Jolie had boldly shared her experience which she explained of how and why she had underwent mastectomy to prevent the risk of developing breast cancer in the future when she found that mutations in the BRCA1 gene were detected in the genetic testing of hereditary breast ovarian cancer via New York Times The Opinion Pages, the news had turned into a hot topic in Japan.
At almost the same time, “New prenatal diagnosis” was available for the pregnant women to determine the presence of chromosomal abnormalities in fetal blood test in April this year. As the genetic analysis technology advances, examining and predicting future disease of the baby through fetal genetic testing is made possible. However, this has also accompanied with difficult choices to make. Fear is also voiced as the technology may lead to discrimination of people with possible diseases.
We invited Chieko Tamura, the only person in Japan who holds both American and Japanese certificates as a genetic counselor to share with us the current situation and challenges of genetic counseling and genetic testing.
(medium: Japanese)
■Theme
“Why
did Angelina Jolie undergo the surgery? – a perspective of a certified
genetic counselor from both Japan and the United States with regards to
the current situation and challenges of genetic counseling and genetic
testing.”
■Speaker
Chieko Tamura
Chieko Tamura originally studied pharmaceutical science, and has a Japanese national license as a pharmacist, since 1988. After working for a pharmaceutical company for thirteen years as a basic and clinical research scientist and a product manager, she went to the U.S.A. as a Fulbright scholar and studied genetic counseling at the joint graduate program of the National Human Genome Research Institute and Johns Hopkins University School of Public Health, and graduated in 2003 getting the master’s degree. She has been certified as a genetic counselor by the American Board of Genetic Counseling as well as the Japanese Board of Genetic Counseling. She is currently the only person who holds both American and Japanese certificates as a genetic counselor, and is now a board member of the Japanese Association of Certified Genetic Counselors. After returning to Japan in 2003, she worked as a genetic counselor, at many different medical institutions, including the Japan’s National Center for Child Health and Development, several university hospitals and major fertility clinics, covering a variety of conditions, including prenatal, pediatrics, adult genetics, cancer genetics, neurogenetics, and infertility, etc. Ms. Tamura also worked as an associate professor for five years at one of the newly established genetic counseling training graduate programs at Ochanomizu University in Tokyo. She has been working as an advisor to several patient and family support groups, with Marfan syndrome, Turner syndrome, prion diseases, familial colon cancer, spinocerebellar ataxia, etc.
■Date and Time
Sep 19, 2013 8:00am-9:00am
■Venue
GARB Marunouchi (2-2-3 Marunouchi, Chiyoda-ku, Tokyo)
Exhibition date:2013-09-19
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)